Heart Disease News and Research

Latest Heart Disease News and Research

Implementing population level changes could avoid up to 50% of deaths from CVD

Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).

24 Jul 2012

Two thirds of obese children have heart disease risk factors

Two out of three severely obese kids already have at least one risk factor for heart disease, suggests research published online in Archives of Disease in Childhood.

24 Jul 2012

Aspirin use appears to reduce risk of Barrett's esophagus

Aspirin use appears to reduce the risk of Barrett's esophagus (BE), the largest known risk factor for esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

24 Jul 2012

Study reveals 50% increased risk of urothelial and colorectal cancers in adulthood

Parents are increasingly conscious of the dangers of childhood obesity. There is a growing recognition of health problems associated with extra pounds, including the risk of diabetes, heart disease, and joint and muscle pain.

24 Jul 2012

New insights into physical demands of surfing

Want to train to become a competitive surfer? You'll need high endurance for paddling with bursts of high-intensity activity and short recovery times, according to a study in the August issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association (NSCA).

24 Jul 2012

NYU Langone's CMC offers tips to avoid injuries during summer

The summer is officially here and more people are playing sports and exercising outdoors. Experts from NYU Langone's Center for Musculoskeletal Care (CMC) offer tips to avoid injuries during these warmer months.

24 Jul 2012

Symposium to support care and management of women with HIV

International AIDS Conference, Washington D.C., USA: Women for Positive Action are holding an interactive satellite symposium at the AIDS 2012 Conference entitled Turning the tide in the care of women living with HIV, supporting the care and management of women living with HIV throughout their different life stages.

24 Jul 2012

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

The U.S. Food and Drug Administration today approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm (narrowing of the airways in the lung) associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

24 Jul 2012

Working poor at heart of Medicaid expansion debate as governors draw line in the sand

Even as state executives such as Texas Gov. Rick Perry and Florida Gov. Rick Scott remain firm in their opposition to the health law's Medicaid expansion, health providers such as Cleveland Clinic CEO and President Tony Cosgrove express their support for it.

23 Jul 2012

Synthetic triterpenoids block development of Parkinson's disease

A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report.

23 Jul 2012

Third-party groups to target health law with new wave of attack ads

Also in the news, the Supreme Court -- especially after the recent health law decision -- is an effective tool to rally fundraising among both Democrats and Republicans. Meanwhile, a defense policy expert suggests presidential candidates focus on long-term military mental health issues. Finally, The Wall Street Journal examines how health care is playing in the Montana Senate race, where candidates are sparring over who is soft on cancer.

23 Jul 2012

Oral immunotherapy hope for egg allergy in children

Oral immunotherapy for the treatment of egg allergy results in desensitization with long-lasting results in three-quarters of children, show study findings.

23 Jul 2012

CHD risk needs separating by glycemic status

People with diabetes not only have a higher incidence of coronary heart disease events compared with people without diabetes, but they differ in the type of risk factors they have for such events, report US researchers.

23 Jul 2012

Walking speeds the way to understanding elderly blood pressure

The first study to examine walking speed, mortality, and blood pressure has shown that frail, elderly adults who have high blood pressure may actually be at a decreased risk for mortality, write researchers in the Archives of Internal Medicine.

23 Jul 2012

Gout independent risk factor for myocardial infarction

Gout is a significant and independent risk factor for the development of myocardial infarction, even in younger patients and those with no other cardiovascular risk factors, researchers report in Rheumatology.

23 Jul 2012

AF deaths more likely on the weekend

In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.

23 Jul 2012

First Edition: July 23, 2012

In this Kaiser Health News video, Greg Millett, a senior policy advisor in the Office of National AIDS Policy, tells Joanne Silberner that the president's National HIV/AIDS Strategy has improved coordination among federal agencies and that the 2010 health law will improve access to care for those living with HIV/AIDS.

23 Jul 2012

Low-calorie sweeteners play an important role for healthy, active people

The International Sweeteners Association (ISA) draws attention to a growing number of experts supporting the message that low calorie sweeteners play an important role for healthy, active people. Used in more than 6,000 products around the world, low calorie sweeteners can significantly reduce the energy density of foods and beverages when used as a substitute for sugar.

23 Jul 2012

Bayer, Onyx and Astellas announce results from Tarceva plus Nexavar Phase 3 trial on HCC

Bayer HealthCare Pharmaceuticals, Onyx Pharmaceuticals, Inc., and Astellas Pharma Inc. today announced that a Phase 3 trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexavar (sorafenib) tablets did not improve overall survival for patients with unresectable hepatocellular carcinoma (HCC) vs. Nexavar alone.

23 Jul 2012

Recent guidelines that recommend cholesterol tests for children fail to weigh health benefits

Recent guidelines recommending cholesterol tests for children fail to weigh health benefits against potential harms and costs, according to a new commentary authored by three physician-researchers at UCSF.

23 Jul 2012